APA Zitierstil

Zhu, V. W., Schrock, A. B., Bosemani, T., Benn, B. S., Ali, S. M., & Ou, S. I. (2018). Dramatic response to alectinib in a lung cancer patient with a novel VKORC1L1-ALK fusion and an acquired ALK T1151K mutation. Lung Cancer (Auckl).

Chicago Zitierstil

Zhu, Viola W., Alexa B. Schrock, Thangavijayan Bosemani, Bryan S. Benn, Siraj M. Ali, und Sai-Hong Ignatius Ou. "Dramatic Response to Alectinib in a Lung Cancer Patient With a Novel VKORC1L1-ALK Fusion and an Acquired ALK T1151K Mutation." Lung Cancer (Auckl) 2018.

MLA Zitierstil

Zhu, Viola W., et al. "Dramatic Response to Alectinib in a Lung Cancer Patient With a Novel VKORC1L1-ALK Fusion and an Acquired ALK T1151K Mutation." Lung Cancer (Auckl) 2018.

Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.